192 related articles for article (PubMed ID: 1930623)
1. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
Nakagami H; Nada M
Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of micronized low-substituted hydroxypropylcellulose as an insoluble swellable matrix for sustained-release tablets.
Nakagami H; Nada M
Drug Des Discov; 1991 Dec; 8(2):103-16. PubMed ID: 1793773
[TBL] [Abstract][Full Text] [Related]
3. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
4. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
Felician WA; Ghaly ES
Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
[TBL] [Abstract][Full Text] [Related]
6. Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation.
Kawashima Y; Takeuchi H; Hino T; Niwa T; Lin TL; Sekigawa F; Kawahara K
Pharm Res; 1993 Mar; 10(3):351-5. PubMed ID: 8464806
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
Cui Q; Zhu Y; Cui J
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin polymer, a new tablet disintegrating agent.
Fenyvest E; Antal B; Zsadon B; Szejtli J
Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
[TBL] [Abstract][Full Text] [Related]
10. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the disintegration properties of microcrystalline cellulose II and commercial disintegrants.
Rojas J; Kumar V
Pharmazie; 2012 Jun; 67(6):500-6. PubMed ID: 22822537
[TBL] [Abstract][Full Text] [Related]
12. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
Hosseini A; Körber M; Bodmeier R
Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
14. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
[TBL] [Abstract][Full Text] [Related]
15. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
Jeong SH; Park K
Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
[TBL] [Abstract][Full Text] [Related]
16. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
Kranz H; Le Brun V; Wagner T
Int J Pharm; 2005 Aug; 299(1-2):84-91. PubMed ID: 15970409
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
[TBL] [Abstract][Full Text] [Related]
18. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
Timmins P; Delargy AM; Howard JR
Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
[TBL] [Abstract][Full Text] [Related]
19. The effects of formulation factors on the moist granulation technique for controlled-release tablets.
Railkar AM; Schwartz JB
Drug Dev Ind Pharm; 2001 Oct; 27(9):893-8. PubMed ID: 11763466
[TBL] [Abstract][Full Text] [Related]
20. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
